Recombinant Burkholderia vietnamiensis Elongation factor Tu (tuf1)

What is Burkholderia vietnamiensis and where is it commonly found?

Burkholderia vietnamiensis is a gram-negative bacterium belonging to the Burkholderia cepacia complex (BCC), which currently encompasses at least 17 closely related species. B. vietnamiensis was first isolated from rice rhizosphere in Vietnam, as evidenced by its type strain LMG 10929 . This organism demonstrates remarkable ecological versatility and has been isolated from diverse environmental and clinical settings.

In environmental contexts, B. vietnamiensis primarily inhabits soil, particularly in agricultural settings, and plant rhizospheres where it can participate in nitrogen fixation. This nitrogen-fixing ability distinguishes it from many other BCC members and makes it potentially beneficial for agriculture. In clinical settings, B. vietnamiensis has been isolated from the respiratory tract of patients with cystic fibrosis (CF), patients with chronic granulomatous disease (CGD), and has recently been identified in animal sources, including a goat nasal swab in the Philippines .

The prevalence of BCC infection among patients with pneumonia has been estimated at 2.60%, with B. vietnamiensis being one of the species isolated . B. vietnamiensis strain Vit1, a recently identified clinical isolate, represents a new sequence type with a unique combination of housekeeping genes (atpD type 27, gltB type 231, gyrB type 16, recA type 22, lepA type 12, phaC type 6, and trpB type 268) . This dual nature as both a potential plant-growth promoting rhizobacterium and an opportunistic human pathogen presents complex research challenges.

What is Elongation factor Tu (tuf1) and what functional role does it serve in bacterial physiology?

Elongation factor Tu (EF-Tu), encoded by tuf genes including tuf1, is a highly conserved GTP-binding protein that plays a central role in bacterial protein synthesis . EF-Tu functions as a critical component of the bacterial translation machinery, with several primary functions that make it essential for cell survival.

The primary role of EF-Tu is to deliver aminoacyl-tRNAs to the ribosome during protein synthesis. It forms a ternary complex with GTP and aminoacyl-tRNA, escorting the latter to the A-site of the ribosome during the elongation phase of translation. Upon correct codon-anticodon pairing, EF-Tu hydrolyzes GTP to GDP, undergoes a conformational change, and releases the aminoacyl-tRNA. This GTPase activity is tightly regulated and essential for proper translation rates.

EF-Tu also contributes to translational accuracy by participating in proofreading mechanisms that ensure correct codon-anticodon pairing. Beyond protein synthesis, EF-Tu has been implicated in "moonlighting" functions including stress response, adhesion to host cells, and cytoskeletal organization.

In bacterial genomes, the number of tuf genes varies by species, with some having a single copy while others possess multiple copies . Most low-G+C-content gram-positive bacteria carry only one tuf gene, while gram-negative bacteria often have multiple copies . The presence of multiple tuf genes might provide redundancy or allow for differential expression under various environmental conditions, potentially contributing to bacterial adaptability.

What are the most effective methods for detecting and identifying B. vietnamiensis in clinical and environmental samples?

Multiple methodological approaches exist for detecting and identifying B. vietnamiensis, each with specific advantages and limitations that researchers should consider when designing their experimental protocols:

• Conventional microbiological methods:

  • Selective media cultivation (e.g., Burkholderia cepacia selective agar)

  • Biochemical testing, which has demonstrated efficiency comparable to automated and molecular methods for genus-level identification

  • Morphological characterization of colonies and microscopic examination

• Automated identification systems:

  • VITEK 2 GN ID Card: Provides genus-level identification with 100% accuracy and can identify BCC as a group

  • VITEK MS (MALDI-TOF): Can identify B. vietnamiensis with 99.9% confidence in most cases

• Molecular identification methods:

  • PCR targeting the groEL gene for genus-level confirmation of Burkholderia

  • 16S rRNA gene-based detection methods, including conventional PCR and newer techniques

  • Recombinase-aided amplification (RAA) assay targeting the 16S rRNA gene with high sensitivity (detecting as few as 10 copies/μL) and specificity

  • Multi-locus sequence typing (MLST) using seven housekeeping genes (atpD, gltB, gyrB, recA, lepA, phaC, and trpB) for definitive species and strain identification

Comparative efficacy of these methods is summarized in Table 1:

The RAA assay represents a particularly promising development, offering advantages of lower cost ($5/sample versus $45/sample for conventional PCR) and dramatically faster detection speed (10 minutes versus >2 hours) while maintaining excellent sensitivity and specificity . For research requiring the highest level of discrimination, whole-genome sequencing remains the definitive method, enabling detailed phylogenetic analysis and strain tracking.

How does B. vietnamiensis relate phylogenetically to other members of the Burkholderia cepacia complex?

Phylogenetic analysis reveals B. vietnamiensis as a distinct species within the Burkholderia cepacia complex (BCC), with specific genetic characteristics that differentiate it from other members. Several molecular approaches provide insights into these phylogenetic relationships:

• 16S rRNA gene analysis provides initial genus-level identification, though it may not always offer sufficient resolution for species-level differentiation within the closely related BCC members .

• Multi-locus sequence typing (MLST) analyzing seven housekeeping genes (atpD, gltB, gyrB, recA, lepA, phaC, and trpB) offers more definitive species identification and strain typing . Recent clinical isolates of B. vietnamiensis have revealed novel sequence types, including isolate Vit1 with a previously uncharacterized combination of alleles .

• Whole-genome sequencing with core genome single-nucleotide polymorphism (SNP) analysis provides the most comprehensive view of phylogenetic relationships, revealing fine-scale population structure.

Recent phylogenetic studies based on core SNPs indicate that B. vietnamiensis isolates can show distinct evolutionary patterns compared to other BCC members. While clinical isolates of B. cepacia from the same geographic region (e.g., China) tend to cluster together phylogenetically, B. vietnamiensis may exhibit more diverse evolutionary relationships . For example, the clinical isolate Vit1 showed no close phylogenetic relationship with other regional strains, suggesting independent evolution or introduction from different sources .

These phylogenetic insights have practical implications for understanding transmission patterns, predicting virulence potential, and developing targeted diagnostic approaches. The genetic distinctiveness of B. vietnamiensis within the BCC also supports the need for species-level identification in clinical settings, as different BCC members may have varying clinical significance and treatment responses.

What are the clinical implications of B. vietnamiensis infections and how do they differ from other BCC members?

B. vietnamiensis, like other BCC members, primarily functions as an opportunistic pathogen affecting individuals with compromised immune systems or underlying conditions. The clinical presentations and implications include:

• Respiratory infections in cystic fibrosis (CF) patients:

  • B. vietnamiensis can colonize the respiratory tract of CF patients, potentially leading to significant morbidity

  • Some strains, such as B. vietnamiensis PC259 isolated from a CF patient in Seattle, have demonstrated the ability to invade respiratory epithelial cells in culture, indicating virulence potential

  • Long-term colonization can lead to accelerated decline in pulmonary function

• Systemic infections in chronic granulomatous disease (CGD):

  • Documented cases include strain FC441, which was recovered from a 9-year-old boy with X-linked recessive CGD who survived septicemia with multiple-organ involvement

  • These infections can be life-threatening and challenging to treat

• Antimicrobial resistance profile:

  • Intrinsic resistance to multiple antibiotics complicates treatment

  • Biofilm formation further contributes to treatment challenges

  • Combination antibiotic therapy is often necessary for effective management

Compared to other BCC members, B. vietnamiensis is generally considered to have somewhat lower virulence, though this varies by strain. Recent molecular epidemiological studies suggest that B. vietnamiensis isolates may show distinct evolutionary patterns compared to other BCC species, with certain clinical isolates like the Vit1 strain displaying separate phylogenetic positioning from other regional strains .

The recent identification of B. vietnamiensis in animal sources, including a goat nasal swab in the Philippines , raises questions about potential zoonotic transmission, though further research is needed to establish this connection definitively. Understanding these clinical implications is essential for developing effective prevention strategies and treatment protocols for vulnerable populations.

How can recombinant B. vietnamiensis Elongation factor Tu be expressed and purified for structural studies?

Expression and purification of recombinant B. vietnamiensis Elongation factor Tu (EF-Tu) for structural studies requires careful optimization of multiple parameters to obtain pure, correctly folded, and functionally active protein. A comprehensive methodological approach includes:

• Gene cloning and expression vector construction:

  • PCR amplification of the tuf1 gene from B. vietnamiensis genomic DNA using high-fidelity polymerase

  • Incorporation of appropriate restriction sites or using recombination-based cloning systems

  • Selection of expression vector with suitable promoter (T7, tac) and fusion tag (His6, GST, MBP)

  • Confirmation of correct sequence through DNA sequencing

• Expression host selection and optimization:

  • E. coli BL21(DE3) or derivatives for high-level expression

  • Arctic Express or Rosetta strains for difficult-to-express proteins

  • Optimization of expression conditions:

    • Temperature: Generally lower temperatures (16-25°C) favor proper folding

    • Inducer concentration: 0.1-1.0 mM IPTG for T7-based systems

    • Duration: 4-24 hours depending on temperature and construct

    • Media composition: Rich media (LB, TB) or defined media for isotope labeling

• Cell lysis and initial purification:

  • Mechanical disruption (sonication, French press) or chemical lysis

  • Inclusion of GTP or GDP (100-200 μM) in lysis buffer to stabilize protein

  • Protease inhibitors to prevent degradation

  • Initial clarification by high-speed centrifugation (20,000-40,000 × g)

• Multi-step chromatographic purification:

  • Immobilized metal affinity chromatography (IMAC) for His-tagged protein

  • Tag removal using specific proteases (TEV, PreScission, etc.)

  • Ion exchange chromatography (typically anion exchange at pH 7.5-8.0)

  • Size exclusion chromatography for final polishing and buffer exchange

• Protein quality assessment:

  • SDS-PAGE and Western blotting to confirm identity and purity

  • Mass spectrometry for accurate mass determination

  • Circular dichroism to evaluate secondary structure

  • Thermal shift assay to assess stability

  • GTPase activity assay to confirm functionality

For structural studies, additional considerations include:

• Buffer optimization through thermal shift assays or differential scanning fluorimetry

• Concentration optimization to prevent aggregation (typically 5-20 mg/mL)

• Crystal screening using commercial sparse matrix screens

• For NMR studies, isotopic labeling (15N, 13C) in minimal media

Challenges specific to B. vietnamiensis EF-Tu include potential codon usage bias in heterologous expression systems and maintaining the native nucleotide-binding properties. Co-expression with molecular chaperones or fusion to solubility-enhancing tags may be necessary if initial expression attempts yield insoluble protein.

What structural and functional differences exist between B. vietnamiensis tuf1 and tuf genes in other bacterial species?

The structural and functional characteristics of B. vietnamiensis tuf1 compared to tuf genes in other bacterial species reveal important evolutionary and functional insights:

• Sequence conservation and variability:

  • Tuf genes rank among the most conserved bacterial genes, reflecting EF-Tu's essential role in translation

  • High sequence conservation exists in the GTP-binding domains (G-domains) containing the signature G-protein motifs

  • Variable regions commonly occur in surface-exposed loops, which may reflect adaptation to specific cellular environments or interaction partners

  • Critical catalytic residues show near-universal conservation across bacterial species

• Domain organization and functional implications:

  • Like other bacterial EF-Tu proteins, B. vietnamiensis EF-Tu consists of three domains:

    • Domain 1: GTP-binding domain (residues ~1-200) containing conserved G-protein motifs

    • Domain 2: Middle domain (residues ~201-300) involved in tRNA binding

    • Domain 3: C-terminal domain (residues ~301-393) also participating in tRNA binding

  • The interdomain interfaces are highly conserved, as they facilitate the conformational changes essential for EF-Tu function

• Copy number and genomic context:

  • While B. vietnamiensis likely has multiple tuf genes (similar to many gram-negative bacteria), this contrasts with most low-G+C-content gram-positive bacteria, which typically carry only one tuf gene

  • In bacteria with multiple tuf genes, the genomic context often differs between copies, with one typically located near other ribosomal protein genes

  • The presence of multiple tuf genes in some bacterial lineages likely results from horizontal gene transfer events, as demonstrated in enterococcal species

• Evolutionary implications:

  • Phylogenetic analysis of tuf genes has revealed horizontal gene transfer events that have shaped bacterial evolution

  • In enterococci, tufA genes branch with Bacillus, Listeria, and Staphylococcus genera, while tufB genes cluster with Streptococcus and Lactococcus

  • Similar evolutionary dynamics may apply to Burkholderia species, potentially influencing the functional characteristics of their EF-Tu proteins

• Functional specialization:

  • In bacteria with multiple tuf genes, each copy may have specialized functions or expression patterns

  • Differential expression under various environmental conditions may contribute to bacterial adaptability

  • The potential functional differentiation between tuf genes in B. vietnamiensis remains to be fully characterized

These structural and functional differences not only enhance our understanding of B. vietnamiensis biology but also provide insights into the evolution of this essential component of the bacterial translation machinery, with potential implications for developing targeted antimicrobial strategies.

How can genomic analysis help differentiate between clinical and environmental strains of B. vietnamiensis?

Genomic analysis provides powerful tools for differentiating between clinical and environmental strains of B. vietnamiensis, offering insights into adaptation, virulence, and epidemiology through several methodological approaches:

• Whole-genome sequencing and comparative genomics:

  • Illumina short-read sequencing provides high accuracy for SNP detection

  • Long-read technologies (PacBio, Oxford Nanopore) enable complete genome assembly, including detection of structural variants

  • Hybrid assembly approaches combine advantages of both technologies

  • Core genome SNP analysis reveals phylogenetic relationships at high resolution

  • Pan-genome analysis identifies genes unique to clinical or environmental isolates

• Characterization of genomic features distinguishing clinical from environmental isolates:

  • Virulence factor repertoire: Clinical isolates may possess additional virulence genes

  • Antibiotic resistance determinants: Often enriched in clinical isolates

  • Genomic islands with atypical GC content or codon usage patterns

  • Mobile genetic elements: Prophages, insertion sequences, integrative conjugative elements

  • Metabolic pathways: Environmental isolates may exhibit broader metabolic versatility

• Multi-locus sequence typing (MLST) and phylogenetic analysis:

  • MLST using seven housekeeping genes (atpD, gltB, gyrB, recA, lepA, phaC, and trpB) provides standardized strain typing

  • Recent findings have shown that clinical B. vietnamiensis isolates may form distinct clades from environmental isolates, as observed with the Vit1 isolate (a new sequence type with atpD type 27, gltB type 231, gyrB type 16, recA type 22, lepA type 12, phaC type 6, and trpB type 268)

  • B. vietnamiensis isolates may show more diverse evolutionary relationships than other BCC species like B. cepacia, whose clinical isolates from the same region often cluster together

• Selective pressure analysis:

  • Calculation of dN/dS ratios to identify genes under positive selection

  • Identification of convergent mutations in independent clinical isolates

  • Analysis of gene loss or pseudogenization events

  • Assessment of recombination rates and patterns

• Practical implementation for strain differentiation:

  • DNA extraction using commercial kits optimized for gram-negative bacteria

  • Quality control of DNA (concentration, purity, integrity) before sequencing

  • Selection of appropriate sequencing technology based on research questions

  • Bioinformatic analysis pipeline incorporating read quality control, assembly, annotation, and comparative analysis

  • Validation of genomic findings through phenotypic testing

These genomic approaches enable researchers to:

• Establish molecular epidemiological links between isolates

• Identify genetic determinants of host adaptation and virulence

• Develop molecular diagnostic tools for specific lineages

• Predict the pathogenic potential of environmental isolates

• Inform infection control and prevention strategies

What are the implications of horizontal gene transfer in the evolution of tuf genes in Burkholderia species?

Horizontal gene transfer (HGT) has profoundly influenced the evolution of tuf genes across bacterial species, with significant implications for Burkholderia:

• Evolutionary dynamics and evidence of tuf gene transfer:

  • Studies in enterococci have demonstrated that tuf genes can be acquired through HGT, resulting in some species possessing two different tuf genes (tufA and tufB) with distinct evolutionary histories

  • Phylogenetic analysis shows that in enterococci, tufA genes branch with Bacillus, Listeria, and Staphylococcus genera, while tufB genes cluster with Streptococcus and Lactococcus

  • Primary structure analysis identified four amino acid residues that are conserved and unique to enterococcal tufB genes and the tuf genes of streptococci and Lactococcus lactis, supporting the HGT hypothesis

  • The enterococcal findings suggest that similar HGT events may have shaped tuf gene evolution in other bacterial groups, including Burkholderia

• Mechanisms facilitating tuf gene HGT:

  • Natural transformation in competent bacteria

  • Phage-mediated transduction

  • Plasmid or conjugative transposon transfer

  • Integration through homologous recombination or site-specific recombination

  • Selection pressure from environmental stresses may favor retention of acquired tuf genes

• Genomic consequences of tuf gene acquisition:

  • Changes in genome organization and synteny around tuf genes

  • Potential disruption or creation of operons

  • Adjustment of regulatory networks to accommodate additional tuf copies

  • Possible co-transfer of nearby genes, creating functional modules

• Functional implications of horizontally acquired tuf genes:

  • Functional divergence between different tuf copies

  • Specialization for different environmental conditions or growth phases

  • Potential contributions to stress tolerance or antibiotic resistance

  • Enhanced translational robustness through redundancy

• Methodological approaches to study HGT of tuf genes:

  • Comparative genomic analysis of tuf gene sequences across Burkholderia species

  • Phylogenetic incongruence testing to identify potential HGT events

  • Analysis of nucleotide composition, codon usage, and GC content to detect anomalies

  • Examination of flanking regions for evidence of mobile genetic elements

  • Experimental validation through gene knockout and complementation studies

The evidence for HGT affecting tuf genes in enterococci strongly suggests that similar evolutionary processes may have shaped the tuf gene repertoire in Burkholderia species. Based on 16S rRNA gene sequence analysis in enterococci, species possessing two tuf genes share a common ancestor, while those with only one tuf gene diverged before that common ancestor . This evolutionary pattern may provide a framework for understanding tuf gene distribution and diversity across Burkholderia species as well.

How can recombinant B. vietnamiensis EF-Tu be utilized in antimicrobial drug discovery?

Recombinant Burkholderia vietnamiensis Elongation factor Tu (EF-Tu) offers several strategic applications in antimicrobial drug discovery, with methodological approaches that can accelerate the development of novel therapeutics:

• High-throughput screening platforms:

  • Development of biochemical assays measuring GTPase activity of purified recombinant EF-Tu

  • Fluorescence-based assays monitoring conformational changes upon inhibitor binding

  • Thermal shift assays (differential scanning fluorimetry) to identify stabilizing compounds

  • Surface plasmon resonance for direct binding studies

  • Methodology implementation:

    • Optimize recombinant EF-Tu purification for stability and activity

    • Establish robust assay conditions with appropriate controls

    • Validate with known inhibitors before screening compound libraries

    • Develop counter-screens to eliminate false positives

• Structure-based drug design:

  • X-ray crystallography or cryo-EM of B. vietnamiensis EF-Tu alone and in complex with inhibitors

  • Computational docking studies to identify potential binding pockets

  • Fragment-based drug discovery to identify chemical scaffolds with binding potential

  • Structure-guided optimization of lead compounds

  • Methodological workflow:

    • Obtain high-resolution structures (≤2.5 Å) of purified protein

    • Identify druggable pockets, particularly those unique to bacterial EF-Tu

    • Design focused chemical libraries targeting these sites

    • Iterate between structural analysis and chemical synthesis

• Resistance mechanism studies:

  • Generation of resistant mutants through in vitro selection

  • Site-directed mutagenesis of recombinant EF-Tu to validate resistance mechanisms

  • Structural characterization of resistant variants

  • Methodological approach:

    • Serial passage experiments with sub-inhibitory concentrations

    • Whole-genome sequencing of resistant isolates

    • Introduction of identified mutations into recombinant EF-Tu

    • Biochemical characterization of mutant proteins

• Development of EF-Tu-targeting antimicrobial peptides:

  • Design of peptides targeting EF-Tu-specific epitopes

  • Cell-penetrating peptides coupled to EF-Tu inhibitors

  • Methodological considerations:

    • In silico prediction of interacting peptide sequences

    • Peptide synthesis and purification

    • Assessment of binding affinity and specificity

    • Evaluation of cellular uptake and antimicrobial activity

• Translation into whole-cell assays:

  • Correlation between biochemical inhibition and whole-cell antimicrobial activity

  • Development of reporter strains to monitor EF-Tu inhibition in vivo

  • Methodological implementation:

    • Minimum inhibitory concentration (MIC) determination

    • Time-kill kinetics to assess bactericidal potential

    • Intracellular infection models for efficacy testing

    • Assessment of resistance development frequency

The advantages of targeting EF-Tu include its essential nature, high conservation among bacteria, and structural differences from human elongation factors. These characteristics make it an attractive target for developing narrow-spectrum antibiotics specifically active against Burkholderia species or broader-spectrum agents targeting multiple bacterial pathogens, depending on the inhibitor design strategy employed.

What molecular techniques are most effective for studying B. vietnamiensis gene expression?

Research into B. vietnamiensis gene expression utilizes several advanced molecular techniques, each with specific advantages for different experimental questions:

• RNA-Seq (transcriptome sequencing):

  • Provides comprehensive, quantitative assessment of the entire transcriptome

  • Allows identification of novel transcripts, alternative splicing events, and non-coding RNAs

  • Enables differential expression analysis under various conditions

  • Methodological workflow:

    • Total RNA extraction with DNase treatment

    • rRNA depletion using commercial kits (Ribo-Zero or equivalent)

    • cDNA library preparation with directional information preservation

    • Next-generation sequencing (typically Illumina platform)

    • Bioinformatic analysis pipeline:

      • Quality control and adapter trimming

      • Mapping to reference genome

      • Quantification of transcript abundance

      • Differential expression analysis

      • Functional enrichment analysis

  • Limitations include RNA degradation challenges and complexity of data analysis

• Quantitative PCR (qPCR):

  • Targeted approach for measuring expression of specific genes

  • Often used to validate RNA-Seq findings

  • Methodological considerations:

    • RNA extraction with stringent quality control (RIN score >7)

    • cDNA synthesis with consistent priming method

    • Primer design following MIQE guidelines

    • Reference gene selection based on expression stability

    • Data analysis using ΔΔCt or standard curve methods

  • Advantages include high sensitivity, wide dynamic range, and accessibility

• Reporter gene systems:

  • Construction of transcriptional fusions between B. vietnamiensis promoters and reporter genes

  • Common reporters include GFP, luciferase, or β-galactosidase

  • Methodological approach:

    • Amplification of promoter regions from B. vietnamiensis

    • Cloning into appropriate reporter vectors

    • Introduction into B. vietnamiensis via conjugation or electroporation

    • Measurement of reporter activity under different conditions

  • Particularly useful for studying gene expression at the single-cell level and in biofilms

• RT-PCR operon mapping:

  • Determines co-transcription of adjacent genes

  • Methodological implementation:

    • Design primers spanning intergenic regions

    • RT-PCR using cDNA as template

    • Verification of amplicon identity by sequencing

  • Essential for understanding gene organization and co-regulation

• 5′ Rapid Amplification of cDNA Ends (5′ RACE):

  • Identifies transcription start sites

  • Methodological workflow:

    • RNA dephosphorylation and decapping

    • RNA adapter ligation to 5′ ends

    • cDNA synthesis and PCR amplification

    • Sequencing of products to determine exact start sites

  • Critical for characterizing promoter architecture

These techniques can be combined to provide comprehensive insights into gene expression patterns, regulatory networks, and adaptive responses of B. vietnamiensis. For studying the tuf1 gene specifically, RNA-Seq can determine its expression level relative to other genes, qPCR can measure changes under different conditions, and promoter fusions can visualize expression patterns in different growth phases or environments.

What are the best experimental models for studying B. vietnamiensis pathogenicity and host interactions?

Investigating B. vietnamiensis pathogenicity requires appropriate experimental models that recapitulate relevant aspects of host-pathogen interactions:

• Cell culture models:

  • Human bronchial epithelial cells:

    • Primary human bronchial epithelial cells (PHBEC)

    • Immortalized lines (16HBE14o-, CFBE41o-)

    • Cystic fibrosis-derived cell lines to model disease-specific interactions

  • Immune cell models:

    • Alveolar macrophages (primary or THP-1 derived)

    • Neutrophil models for inflammatory response studies

    • Chronic granulomatous disease (CGD) cell models with defective NADPH oxidase

  • Methodological approaches:

    • Standardized infection protocols with defined MOI (multiplicity of infection)

    • Gentamicin protection assays to distinguish adhesion from invasion

    • Cytokine profiling using ELISA or multiplex bead arrays

    • Live cell imaging with fluorescently-labeled bacteria

    • Transepithelial electrical resistance measurements for barrier integrity

• Biofilm models:

  • Static biofilm systems:

    • Crystal violet microtiter plate assays for quantification

    • Calgary Biofilm Device for antimicrobial susceptibility testing

  • Dynamic biofilm systems:

    • Flow cells with continuous media perfusion

    • Drip flow reactors mimicking low-shear environments

  • Specialized media formulations:

    • Artificial sputum medium (ASM) mimicking CF lung environment

    • Minimal media with defined carbon sources

  • Analytical methods:

    • Confocal laser scanning microscopy with live/dead staining

    • Extracellular polymeric substance (EPS) quantification

    • Biofilm RNA extraction for transcriptomic analysis

    • Biofilm dispersion assays

• Advanced 3D tissue models:

  • Air-liquid interface cultures:

    • Primary bronchial epithelial cells cultured at air-liquid interface

    • Development of mucociliary differentiation and functional tight junctions

  • Lung-on-a-chip microfluidic devices:

    • Incorporation of mechanical stretching to mimic breathing

    • Co-culture with endothelial cells to model alveolar-capillary barrier

  • Organoids:

    • Patient-derived lung organoids

    • CF organoids for disease-specific studies

  • Experimental protocols:

    • Apical bacterial inoculation mimicking natural infection route

    • Trans-epithelial migration assays

    • Mucociliary clearance assessment

    • Cytokine secretion profiling (basolateral vs. apical)

• Animal models:

  • Mouse models:

    • Wild-type mice for acute infection studies

    • CFTR-deficient mice to model cystic fibrosis

    • CGD mouse models (gp91phox-/- mice)

  • Galleria mellonella (wax moth) larvae:

    • Invertebrate model with temperature-controllable infections

    • High-throughput screening capability

    • Survival curves as virulence readout

  • Methodological considerations:

    • Standardized inoculation routes (intranasal, intratracheal)

    • Bacterial burden quantification in tissues

    • Histopathological analysis

    • Inflammatory marker profiling

    • In vivo imaging with bioluminescent bacteria

Selection criteria for appropriate models should consider:

• Research question specificity (e.g., biofilm formation, invasion, immune evasion)

• Relevance to natural infection process

• Ethical considerations and availability of facilities

• Throughput requirements and cost constraints

• Translation potential to human disease

Combining multiple model systems often provides the most comprehensive understanding of B. vietnamiensis pathogenicity, with in vitro models enabling detailed mechanistic studies and animal models providing integrated host response data.

How do mutations in the tuf1 gene affect antibiotic resistance in B. vietnamiensis?

Mutations in the tuf1 gene can significantly impact antibiotic resistance in B. vietnamiensis, particularly for antibiotics targeting protein synthesis:

• Mechanisms of tuf1-mediated resistance:

  • Target site modifications: Amino acid substitutions in EF-Tu can reduce binding affinity for antibiotics that directly target this protein

  • Allosteric effects: Mutations may cause conformational changes that indirectly affect ribosome-antibiotic interactions

  • Compensatory adaptations: tuf1 mutations may offset fitness costs associated with other resistance mechanisms

  • Translation kinetics alteration: Changes in EF-Tu function can modify elongation rates, affecting the sensitivity to time-dependent antibiotics

• Classes of antibiotics affected by tuf1 mutations:

  • Kirromycin and related compounds that directly bind to EF-Tu

  • Aminoglycosides (indirect effects through altered translation fidelity)

  • Tetracyclines (altered ribosomal binding dynamics)

  • Other protein synthesis inhibitors (variable effects depending on mutation location)

• Structure-function relationships in resistance-associated mutations:

  • GTP-binding domain mutations: Affect nucleotide binding/hydrolysis and conformational cycling

  • tRNA-binding interface mutations: Modify interactions with aminoacyl-tRNAs

  • Ribosome-binding surface mutations: Alter EF-Tu-ribosome interactions

  • Domain interface mutations: Disrupt conformational changes essential for function

• Experimental approaches to study tuf1 mutations and resistance:

  • Site-directed mutagenesis:

    • Introduction of specific mutations based on structural predictions

    • Expression of mutant proteins in heterologous systems

    • Biochemical characterization of purified variants

  • Selection of resistant mutants:

    • Serial passage with increasing antibiotic concentrations

    • Whole-genome sequencing to identify tuf1 mutations

    • Complementation studies to confirm causality

  • Phenotypic characterization:

    • Minimum inhibitory concentration (MIC) determination

    • Growth curve analysis under antibiotic stress

    • Competition assays to assess fitness costs

    • Ribosome profiling to examine translation effects

• Clinical implications:

  • Surveillance for tuf1 mutations in clinical isolates showing unexpected resistance

  • Design of molecular diagnostics to detect known resistance-associated mutations

  • Development of novel antibiotics less affected by common tuf1 mutations

  • Combination therapy strategies to prevent resistance emergence

A particularly concerning aspect of tuf1 mutations is that they may confer cross-resistance to multiple antibiotic classes, potentially limiting treatment options for B. vietnamiensis infections, especially in vulnerable populations like cystic fibrosis patients. Additionally, because EF-Tu is essential, resistant variants must maintain functionality, creating a narrow evolutionary space that might be exploited in drug design strategies.